Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

De Rijksmiddelen

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    De Rijksmiddelen. De Economist 21, 83–120 (1872). https://doi.org/10.1007/BF02180633

    Download citation